Mini Review
Published on 14 Mar 2013
Mechanisms and insights into drug resistance in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00028
- 61,873 views
- 507 citations
Type at least 3 characters
2,220 articles
Articles
Review
Published on 12 Mar 2013
Cardiotoxicity of Cancer Therapeutics: Current Issues in Screening, Prevention, and Therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00019
- 9,845 views
- 33 citations
Perspective
Published on 11 Mar 2013
Physician Recruitment of Patients to Non-Therapeutic Oncology Clinical Trials: Ethics Revisited
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00025
- 6,990 views
- 5 citations
Review
Published on 06 Mar 2013
Extracellular Vesicles – Biomarkers and Effectors of the Cellular Interactome in Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00021
- 14,049 views
- 165 citations
Mini Review
Published on 27 Feb 2013
Resistance to PARP-Inhibitors in Cancer Therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00018
- 16,042 views
- 84 citations
Review
Published on 13 Feb 2013
Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00015
- 20,779 views
- 50 citations
Review
Published on 12 Feb 2013
Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00013
- 18,545 views
- 79 citations
Original Research
Published on 12 Feb 2013
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00009
- 5,403 views
- 4 citations
Mini Review
Published on 11 Feb 2013
The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00010
- 15,321 views
- 109 citations
Mini Review
Published on 06 Feb 2013
Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00003
- 7,045 views
- 19 citations
Review
Published on 31 Jan 2013
Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00005
- 22,969 views
- 127 citations
Methods
Published on 28 Jan 2013
Clonal Evolution and Therapeutic Resistance in Solid Tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00002
- 7,983 views
- 20 citations
Hypothesis and Theory
Published on 27 Dec 2012
Is There an Epigenetic Component Underlying the Resistance of Triple-Negative Breast Cancers to Parp Inhibitors?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00202
- 7,755 views
- 4 citations
Mini Review
Published on 07 Nov 2012
Metastasis-Associated Cell Surface Oncoproteomics
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00192
- 7,383 views
- 11 citations
Mini Review
Published on 11 Sep 2012
The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00164
- 7,311 views
- 14 citations
Mini Review
Published on 30 Jul 2012
Recurrent Oral Cancer: Current and Emerging Therapeutic Approaches
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2012.00149
- 24,239 views
- 102 citations